Capa

THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION IBD

PHARMAGELLAN, LLC
01 / 2017
9780998407500
Inglês

Sinopse

If you',re a biotech executive, investor, deal maker, entrepreneur, or adviser&mdash,or aspire to be one&mdash,then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs.THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies.&bull, Vetted benchmarks for key drivers of income, expenses, and valuation.&bull, Proprietary analyses by Pharmagellan',s experienced consulting team.&bull, More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.Whether you',re making investment decisions, pitching to potential partners or funders, or assessing your own R&D program, this is the one-stop guide you need by your side.